A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in post-menopausal ...
Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both We measured mammographic percent density and serum ...
Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, ...
Weight-loss jabs could have a hidden benefit for a particular group of breast cancer patients, a new study has found. Scientists studying the “overlooked” hormone estrone, which is produced in fat ...
In a recent study published in eBioMedicine, researchers determine the genetic regulation of blood estrone levels in postmenopausal women to explore associations between their genetic loci and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results